Membrane binding and anticoagulant properties of protein S natural variants

Thrombosis Research

Volumn 125, Issue 2, 2010, Pages

  Baroni, Marcello ^a   Pavani, Giulia ^b   Marescotti, Diego ^a   Kaabache, Tahar ^c   Borgel, Delphine ^d   Gandrille, Sophie ^e   Marchetti, Giovanna ^a   Legnani, Cristina ^f   D'Angelo, Armando ^b   Pinotti, Mirko ^a   Bernardi, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSERM   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

oxidized phospholipids; protein S activity; protein S deficiency; protein S domains; protein S membrane binding; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; ANTIBODY; BLOOD CLOTTING FACTOR 10A; CALCIUM; COMPLEMENT COMPONENT C4 BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; LIPOSOME; MUTANT PROTEIN; PHOSPHATIDYLSERINE; PROTEIN S; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTICOAGULATION; APOPTOSIS; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CELL ADHESION; CELL SUSPENSION; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENDOGENOUS THROMBIN POTENTIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE MUTATION; INFLAMMATION; MEMBRANE BINDING; MUTATION; NONHUMAN; OXIDATION; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PURIFICATION; PROTEIN S DEFICIENCY; PROTEIN VARIANT; THROMBIN TIME;

ANIMALS; ANTICOAGULANTS; BINDING SITES; BLOOD COAGULATION; CELL LINE; CELL LINE, TRANSFORMED; CELL MEMBRANE; CELL TRANSFORMATION, VIRAL; CRICETINAE; FIBROBLASTS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS; HUMANS; KIDNEY; LIPOSOMES; MEMBRANES; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN C; PROTEIN CONFORMATION; PROTEIN S; PROTEIN S DEFICIENCY; RECOMBINANT PROTEINS; SIMIAN VIRUS 40;

EID: 76449114342     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.09.015     Document Type: Article

References (42)

1. Di Scipio R.G., and Davie E.W. Characterization of protein S, a alpha-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry 18 (1979) 899-904
2. Castoldi E., and Hackeng T.M. Regulation of coagulation by protein S. Curr Opin Hematol 15 (2008) 529-536
3. Rezende S.M., Simmonds R.E., and Lane D.A. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 103 (2004) 1192-1201
4. Hackeng T.M., Seré K.M., Tans G., and Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci 103 (2006) 3106-3311
5. Hackeng TM, Rosing J. Protein S as Cofactor for TFPI. Arterioscler Thromb Vasc Biol. 2009,6. [Epub ahead of print]
6. Furie B., Bouchard B.A., and Furie B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 93 (1999) 1798-1808
7. Walker F.J. Protein S and the regulation of activated protein C. Semin Thromb Hemost 10 (1984) 131-138
8. Fernández-Fernández L., Bellido-Martín L., and García de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 100 (2008) 604-610
9. Oksjoki R., Kovanen P.T., Mäyränpää M.I., Laine P., Blom A.M., Meri S., and Pentikäinen M.O. Complement regulation in human atherosclerotic coronary lesions. Immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway. Atherosclerosis 192 (2007) 40-48
10. Safa O., Hensley K., Smirnov M.D., and Esmon C.T. Esmon NL.Lipid oxidation enhances the function of activated protein C. J Biol Chem 276 (2001) 1829-1836
11. Weinstein E.A., Li H., Lawson J.A., Rokach J., FitzGerald G.A., and Axelsen P.H. Prothrombinase acceleration by oxidatively damaged phospholipids. J Biol Chem 275 (2000) 22925-22930
12. Schwalbe R., Dahlback B., Hillarp A., and Nelsestuen G. Assembly of protein S and C4b-binding protein on membranes. J Biol Chem 265 (1990) 16074-16081
13. Dahlback B., and Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci 78 (1981) 2512-2516
14. Maurissen L.F., Thomassen M.C., Nicolaes G.A., Dahlbäck B., Tans G., Rosing J., and Hackeng T.M. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood 111 (2008) 3034-3041
15. Baroni M., Mazzola G., Kaabache T., Borgel D., and Gandrille S. Vigano' D'Angelo S, Marchetti G, di Iasio MG, Pinotti M, D'Angelo A, Bernardi F. Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function. J Thromb Haemost 4 (2006) 186-191
16. Formstone C.J., Wacey A.I., Berg L.P., Rahman S., Bevan D., Rowley M., Voke J., Bernardi F., Legnani C., Simioni P., Girolami A., Tuddenham E.G., Kakkar V.V., and Cooper D.N. Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. Blood 86 (1995) 2632-2641
17. Rezende S.M., Lane D.A., Zoller B., Mille-Baker B., Laffan M., and Dalhback B. Simmonds RE Genetic and phenotypic variability between families with hereditary protein S deficiency. Thromb Haemost 87 (2002) 258-265
18. D'Angelo A., and D'Angelo V. Protein S deficiency. Haematology 93 (2008) 498-501
19. Persson K.E., Stenflo J., Linse S., Stenberg Y., Preston R.J., Lane D.A., and Rezende S.M. Binding of calcium to anticoagulant protein S: role of the fourth EGF module. Biochemistry 45 (2006) 10682-10689
20. Reali E., Guerrini R., Giori B., Borghi M., Marastoni M., Tomatis R., Traniello S., Masucci M.G., and Gavioli R. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides. Clin Exp Immunol 105 (1996) 369-375
21. Morboeuf O., Borgel D., Aiach M., Kaabache T., Gandrille S., and Gaussem P. Expression and characterization of recombinant protein S with the Ser 460 Pro mutation. Thromb Res 100 (2000) 81-88
22. Price P.A. Analysis for gamma-carboxyglutamic acid. Method Enzymol 91 (1983) 13-17
23. Sun Y.M., Jin D.Y., Camire R.M., and Stafford D.W. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X. Blood 106 (2005) 3811-3815
24. Arruda V.R., Hagstrom J.N., Deitch J., Heiman-Patterson T., Camire R.M., Chu K., Fields P.A., Herzog R.W., Couto L.B., Larson P.J., and High K.A. Posttranslational modifications of recombinant myotube-synthesized human factor IX. Blood 97 (2001) 130-138
25. Saller F., Villoutreix B.O., Amelot A., Kaabache T., Le Bonniec B.F., Aiach M., Gandrille S., and Borgel D. The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding. Blood 105 (2005) 122-130
26. Al Dieri R., Peyvandi F., Santagostino E., Giansily M., Mannucci P.M., Schved J.F., Béguin S., and Hemker H.C. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 88 (2002) 576-582
27. Hemker H.C., Giesen P.L.A., Ramjee M., Wagenvoord R., and Beguin S. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 83 (2000) 589-591
28. Marchetti G., Caruso P., Lunghi B., Pinotti M., Lapecorella M., Napolitano M., Canella A., Mariani G., and Bernardi F. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 6 (2008) 797-803
29. Smirnov M.D., and Esmon C.T. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 269 (1994) 816-819
30. Seré K.M., Janssen M.P., Willems G.M., Tans G., and Rosing J. Hackeng TM.Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity. Biochemistry 40 (2001) 8852-8860
31. Dielis A.W., Castoldi E., Spronk H.M., van Oerle R., Hamulyák K., Ten Cate H., and Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 6 (2008) 125-131
32. Duchemin J., Pan-Petesch B., Arnaud B., Blouch M.T., and Abgrall J.F. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 99 (2008) 767-773
33. Stenflo J., Stenberg Y., and Muranyi A. Calcium-binding EGF-like modules in coagulation proteinases: function of the calcium ion in module interactions. Biochim Biophys Acta 1477 (2000) 51-63
34. Bettache N., Gaffet P., Allegre N., Maurin L., Toti F., Freyssinet J.M., and Bienvenüe A. Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome. Br J Haematol 101 (1998) 50-58
35. Lamba O.P., Lal S., Yappert M.C., Lou M.F., and Borchman D. Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system. Biochim Biophys Acta 1081 (1991) 181-187
36. Villoutreix B.O. Garcia de Frutos P, Lovenklev M, Linse S, Fernlund P, Dahlback B. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins 29 (1997) 478-491
37. Marchetti G., Legnani C., Patracchini P., Gemmati D., Ferrati M., Palareti G., Coccheri S., and Bernardi F. Study of a protein S gene polymorphism at DNA and mRNA level in a family with symptomatic protein S deficiency. Br J Haematol 85 (1993) 173-175
38. Gandrille S., Borgel D., Sala N., Espinosa-Parrilla Y., Simmonds R., Rezende S., Lind B., Mannhalter C., Pabinger I., Reitsma P.H., Formstone C., Cooper D.N., Saito H., Suzuki K., and Bernardi F. Aiach M; Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Protein S deficiency: a database of mutations-summary of the first update. Thromb Haemost 84 (2000) 918
39. Castoldi E., Simioni P., Kalafatis M., Lunghi B., Tormene D., Girelli D., Girolami A., and Bernardi F. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood 96 (2000) 1443-1448
40. Tirado I., Mateo J., Soria J.M., Oliver A., Borrell M., Coll I., Vallvé C., Souto J.C., Martínez-Sánchez E., and Fontcuberta J. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies. Haematologica 86 (2001) 1200-1208
41. Castoldi et al, ISTH 2009,abstract # 2338.
42. Kask L., Trouw L.A., Dahlback B., and Blom A.M. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J Biol Chem 279 (2004) 23869-23873